USPTO Office Action, and Myriad Genetics' Subsequent Response
| dc.contributor.author | United States Patent and Trade Office | |
| dc.contributor.author | Myriad Genetics, Inc. | |
| dc.date.accessioned | 2013-07-16T01:50:17Z | |
| dc.date.available | 2013-07-16T01:50:17Z | |
| dc.date.issued | 1997 | |
| dc.description | The USPTO requested that Myriad restrict its application to one invention, and suggested ways to group claims in distinct inventions; Myriad responded with alternate combinations of claims into fewer new distinct inventions. | |
| dc.identifier.uri | ||
| dc.language.iso | en_US | |
| dc.subject | Genetics, Myriad Genetics, BRCA, Breast Cancer, Gene Patents, Law, Health Policy, Medicine, Women’s Health | |
| dc.title | USPTO Office Action, and Myriad Genetics' Subsequent Response | |
| dc.type | Other |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- pto office action and myriad's response.Jan 6 and Feb 5 1997.pdf
- Size:
- 464.2 KB
- Format:
- Adobe Portable Document Format
- Description:
- USPTO Office Action and Myriad's Response